These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24485669)

  • 1. Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study.
    Masoura S; Kalogiannidis I; Makedou K; Theodoridis T; Koiou K; Gerou S; Athanasiadis A; Agorastos T
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():119-23. PubMed ID: 24485669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
    Vatten LJ; Åsvold BO; Eskild A
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia.
    Pinheiro CC; Rayol P; Gozzani L; Reis LM; Zampieri G; Dias CB; Woronik V
    Prenat Diagn; 2014 Nov; 34(11):1084-92. PubMed ID: 24916790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
    Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
    Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating angiogenic factors and their association with birth outcomes in preeclampsia.
    Kulkarni AV; Mehendale SS; Yadav HR; Kilari AS; Taralekar VS; Joshi SR
    Hypertens Res; 2010 Jun; 33(6):561-7. PubMed ID: 20224572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia.
    Varughese B; Bhatla N; Kumar R; Dwivedi SN; Dhingra R
    Natl Med J India; 2010; 23(2):77-81. PubMed ID: 20925202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia.
    Cui L; Shu C; Liu Z; Tong W; Cui M; Wei C; Tang JJ; Liu X; Hu J; Jiang J; He J; Zhang DY; Ye F; Li Y
    Pregnancy Hypertens; 2018 Jul; 13():127-132. PubMed ID: 30177039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
    March MI; Geahchan C; Wenger J; Raghuraman N; Berg A; Haddow H; Mckeon BA; Narcisse R; David JL; Scott J; Thadhani R; Karumanchi SA; Rana S
    PLoS One; 2015; 10(5):e0126815. PubMed ID: 25965397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
    Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
    Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preeclampsia and superimposed preeclampsia: The same disease? The role of angiogenic biomarkers.
    Costa RA; Hoshida MS; Alves EA; Zugaib M; Francisco RP
    Hypertens Pregnancy; 2016 May; 35(2):139-49. PubMed ID: 26930132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
    Dröge L; Herraìz I; Zeisler H; Schlembach D; Stepan H; Küssel L; Henrich W; Galindo A; Verlohren S
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):286-93. PubMed ID: 25491901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers.
    Tsao PN; Wei SC; Su YN; Chou HC; Chen CY; Hsieh WS
    Pediatrics; 2005 Aug; 116(2):468-72. PubMed ID: 16061605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].
    Boulanger H; Lefèvre G; Ahriz Saksi S; Achiche J; Bailleul S; Ekoukou D; Drouin D; Sault C; Stawiarski N; Dupuis E
    Nephrol Ther; 2019 Nov; 15(6):413-429. PubMed ID: 30935786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.
    Wallner W; Sengenberger R; Strick R; Strissel PL; Meurer B; Beckmann MW; Schlembach D
    Clin Sci (Lond); 2007 Jan; 112(1):51-7. PubMed ID: 16928195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.